HELPING THE OTHERS REALIZE THE ADVANTAGES OF MBL77

mutations supplied the fact that, as explained under, CLL therapy relies to the presence or absence of such mutations. The current consensus is the fact that, in addition to clonal mutations, subclonal mutations that has a variant allelic frequency ranging from 5 to 10% (and as a consequence under the threshold of detection by traditional molecular